InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,827.71
(
-2.53%
)

Replies to post #19570 on Intellect Neurosciences Inc. (fka ILNS)

Replies to #19570 on Intellect Neurosciences Inc. (fka ILNS)

Stately

02/20/16 4:42 PM

#19571 RE: montanus #19570

I'm guessing this means your perspective is that the ponezumab Phase II trial was successful and the recent activity is a result of that?